エピソード

  • Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

    Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
    2025/07/29

    Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer.

    CME information and select publications here.

    続きを読む 一部表示
    28 分
  • Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

    Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
    2025/07/04

    Dr Harold Burstein, Dr Javier Cortés, Prof Rebecca A Dent, Dr Kevin Kalinsky, Dr Joyce O’Shaughnessy and moderator Dr Hope S Rugo present data informing treatment decision-making for patients with metastatic breast cancer at the 2025 ASCO annual meeting.

    CME information and select publications here.

    続きを読む 一部表示
    1 時間 58 分
  • IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

    IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
    2025/06/23

    Dr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas.

    CME information and select publications here.

    続きを読む 一部表示
    54 分
  • For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress

    For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress
    2025/06/16

    Drs Virginia F Borges and Seth Wander summarize the treatment landscape for patients with hormone receptor-positive breast cancer, supported with clinical perspectives and management strategies from nurse practitioners Ms Jamie Carroll and Mr Ronald Stein.

    NCPD information and select publications here.

    続きを読む 一部表示
    1 時間 55 分
  • Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances

    Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
    2025/06/04

    Dr Ian Krop from Yale Cancer Center in New Haven, Connecticut, and Dr Sara Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with breast cancer.

    CME information and select publications here.

    続きを読む 一部表示
    1 時間 1 分
  • 5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

    5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    2025/05/28

    Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.

    CME information and select publications here.

    続きを読む 一部表示
    14 分
  • 5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

    5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    2025/05/19

    Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.

    CME information and select publications here.

    続きを読む 一部表示
    18 分
  • Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

    Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
    2025/05/06

    Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.

    CME information and select publications here.
    続きを読む 一部表示
    1 時間